Showing results (1031-1040 of 1,055) with videos related to
Sort By:
Pageof 106
The World Allergy Organization Journal|February 16, 2024
Updated grading system for systemic allergic reactions: Joint Statement of the World Allergy Organization Anaphylaxis Committee and Allergen Immunotherapy CommitteePaul J Turner, Ignacio J Ansotegui, Dianne E Campbell, et al.Nature Communications|October 13, 2011
A mitochondria-targeted inhibitor of cytochrome c peroxidase mitigates radiation-induced deathJeffrey Atkinson, Alexandr A Kapralov, Naveena Yanamala, et al.Journal of Leukocyte Biology|May 10, 2019
Redox (phospho)lipidomics of signaling in inflammation and programmed cell deathYulia Y Tyurina, Claudette M St Croix, Simon C Watkins, et al.Nature|June 4, 2013
The bromodomain protein Brd4 insulates chromatin from DNA damage signallingScott R Floyd, Michael E Pacold, Qiuying Huang, et al.Eclinicalmedicine|May 2, 2023
SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational studyJoshua A Hill, Michael J Martens, Jo-Anne H Young, et al.Nature Chemical Biology|February 22, 2020
Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic deathAlexandr A Kapralov, Qin Yang, Haider H Dar, et al.Medrxiv : the Preprint Server for Health Sciences|February 12, 2024
SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101)Joshua A Hill, Michael J Martens, Jo-Anne H Young, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2024
SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational StudyJoshua A Hill, Michael J Martens, Jo-Anne H Young, et al.Communications Biology|June 4, 2021
Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differencesWalter Rayford, Alp Tuna Beksac, Jordan Alger, et al.Proceedings of the National Academy of Sciences of the United States of America|June 16, 2023
Discovering selective antiferroptotic inhibitors of the 15LOX/PEBP1 complex noninterfering with biosynthesis of lipid mediatorsHaider H Dar, Karolina Mikulska-Ruminska, Yulia Y Tyurina, et al.Pageof 106